Sequencing Kits Market by Type (Nucleic Acid Extraction & Amplification, Library Preparation, Control) Technology (NGS, Sanger) Application (Drug Discovery, Oncology, Reproductive Health, Infectious Diseases) End User - Global Forecast to 2030

The global sequencing kits market is projected to reach $21.9 billion by 2030, at a CAGR of 15.3% from 2023 to 2030.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the sequencing kits & reagents market is driven by the increasing prevalence of cancer & genetic disorders, rising healthcare expenditures, increasing funding for research activities, the surge in genome mapping programs, the decreasing costs of sequencing procedures, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, the improving regulatory and reimbursement scenarios for NGS-based diagnostic tests, and government initiatives promoting the use of sequencing in clinical & research applications. However, the high costs of sequencing kits & reagents and the ethical & legal issues related to DNA sequencing-based diagnosis are factors restraining the growth of this market.

Moreover, government support for large-scale genomic sequencing projects, the increasing applications of genome sequencing in disease diagnostics and precision medicine, emerging economies, and advancements in genomics & proteomics are expected to generate growth opportunities for market stakeholders. However, the evolving regulatory landscape, the low chances of positive, actionable mutations, and the lack of sequencing professionals in developing countries are major challenges for market growth.

Additionally, developing portable sequencing technologies and increasing partnerships & collaborations among NGS product manufacturers to expand and improve product offerings are prominent trends in the sequencing kits & reagents market.

Based on type, in 2023, the nucleic acid extraction & amplification kits & reagents segment is expected to account for the largest share of the market. This segment's large market share is attributed to the growing adoption of sequencing-based research and development by various end users, such as pharmaceutical & biopharmaceutical companies and academic & research institutes.

Based on technology, in 2023, the next-generation sequencing (NGS) segment is expected to account for the largest share of the market. The large market share of the segment is attributed to the growing adoption of NGS in clinical and research settings, its ability to provide faster and more accurate genetic testing, the rapidly declining cost of sequencing per base, and the introduction of cost-effective benchtop laboratory sequencers.

Based on application, the research applications segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the rising incidence of cancer, the growing demand for precision medicine, the increased discovery of biomarkers, and the availability of cost-effective advanced sequencing technologies like NGS, SMRT, and nanopore for research applications.

Based on end user, in 2023, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the declining costs of sequencing, the development of companion diagnostics and precision medicine, and the rising demand for sequencing from pharmaceutical and biopharmaceutical companies, primarily for drug discovery purposes.

An in-depth analysis of the geographical scenario of the global sequencing kits & reagents market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the sequencing kits & reagents market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America’s significant market share can be attributed to factors such as the rising burden of cancer, the presence of key market players, well-established healthcare infrastructure, and government initiatives supporting sequencing projects.

The key players operating in the global sequencing kits & reagents market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China).

Scope of the Report:

Sequencing Kits & Reagents Market Assessment—by Type

Control Kits & Reagents
Library Preparation Kits & Reagents
Nucleic Acid Extraction & Amplification Kits & Reagents
Sequencing Kits & Reagents
Other Kits & Reagents

Note: Other kits & reagents include fluorescent dye, polyacrylamide gel, adenosine phosphosulphate (APS), luciferin, apyrase, probes, barcode kits, flow cells, trays, and beads

Sequencing Kits & Reagents Market Assessment—by Technology

Next-generation Sequencing
Sanger Sequencing
Third & Fourth-generation Sequencing
Other Sequencing Technologies

Note: Other technologies include pyro sequencing, degradome sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing

Sequencing Kits & Reagents Market Assessment—by Application

Research Applications
Drug Discovery
Agricultural & Animal Research
Other Research Applications
Clinical Applications
Reproductive Health
Oncology
Infectious Diseases
Other Clinical Applications

Note: Other research applications include food microbiology, microbial analysis in the beverage industry, and environmental studies.

Note: Other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, and metabolic and immune disorders

Sequencing Kits & Reagents Market Assessment—by End User

Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Academic & Research Institutes
Other End Users

Note: Other end users include forensic laboratories & security agencies, food & beverage companies, and agriculture companies

Sequencing Kits & Reagents Market Assessment—by Geography

North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa

Sequencing Kits Market - Report Summary

Report Metrics	Details
Years Considered	2021 - 2030
Base Year	2022
Forecast Period	2023-2030
Page Count	260
Units Referenced	Value (USD Million)
Segments/Key Topics	Market by Type, Technology, Application, End User, and Geography
Regions Covered	North America, Europe, Asia–Pacific, Latin America, and Middle East & Africa
Key Companies Mentioned	Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China).

FAQs About the Report

What is the focus of the sequencing kits & reagents market study?

This study offers a detailed assessment of the sequencing kits & reagents market based on type, technology, application, and end user. This report also involves the value analysis of various segments and subsegments of the sequencing kits & reagents market at the regional and country levels.

What is the revenue generated from the sequencing kits & reagents market across the globe? At what rate is their demand expected to grow for the next 5–7 years?

The sequencing kits & reagents market is projected to reach $21.9 billion by 2030, at a CAGR of 15.3% during the forecast period.

Based on type, which segment is expected to hold the largest share of the market in 2023?

The nucleic acid extraction & amplification kits & reagents segment is expected to account for the largest share of the sequencing kits market in 2023.

Based on technology, which segment is expected to hold the largest share of the market in 2023?

The next-generation sequencing (NGS) segment is expected to account for the largest share of the market in 2023. The large market share of this segment is attributed to the higher sensitivity of this technique to call variants, low sequencing costs compared to other sequencing technologies, and the availability of low-cost sequencers.

Which application segment is expected to hold the largest share of the market in 2023?

The research applications segment is expected to hold the largest share of the sequencing kits market in 2023. The large market share of this segment is attributed to the rising incidence of cancer, the growing demand for precision medicine, the increased discovery of biomarkers, and the availability of cost-effective advanced sequencing technologies like NGS and SMRT within research protocols.

Which end user segment is expected to hold the largest share of the market in 2023?

The pharmaceutical & biotechnology companies segment is expected to hold the largest share of the sequencing kits market in 2023. The large market share of this segment is attributed to rising research efforts in drug discovery, the growing demand for precision medicine, and the increasing number of cancer studies aimed at advancing cancer treatment.

What are the key factors supporting the growth of this market? What are the major opportunities for existing market players and new entrants in the sequencing kits market?

The growth of the sequencing kits market along with sequencing reagents is driven by the increasing prevalence of cancer & genetic disorders, rising healthcare expenditures, increasing funding for research activities, the surge in genome mapping programs, the decreasing costs of sequencing procedures, the growing need for early detection and prevention of diseases, technological advancements in sequencing products, the improving regulatory and reimbursement scenarios for NGS-based diagnostic tests, and government initiatives promoting the use of sequencing practices in clinical & research applications.

Who are the major players operating in the sequencing kits market?

The key players profiled in the sequencing kits market along with sequencing reagents study are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China).

Which regions/countries are expected to offer significant growth opportunities for the market players operating in the sequencing kits market?

Emerging economies such as China and India are projected to offer significant growth opportunities to the market players due to rising investments in the healthcare sector and increasing genomic projects in these countries.